-transparent.png){kind=logo}
Anthracycline antibiotic 2-hydroxyaclacinomycins. I. 2-Hydroxyaclacinomycin-producing recombinant obtained from aclacinomycin-blocked mutants of Streptomyces galilaeus by a technique of protoplast fusion. 1991
Central Research Laboratories, Mercian Corporation, Kanagawa, Japan.
The technique of protoplast fusion which optimized prototrophic recombination in aclacinomycin-producing Streptomyces galilaeus was studied and applied to the construction of new anthracycline analog-producing recombinant upon genetic cross of two specific mutants blocked in aclacinomycin biosynthesis. Thus, 2-hydroxyaclacinomycin-producing recombinant was obtained by the protoplast fusion.
Related Publications
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
May 1996,
Bioscience, biotechnology, and biochemistry,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
January 1986,
Journal of basic microbiology,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
June 1994,
Microbiology (Reading, England),
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
January 1990,
Chinese journal of biotechnology,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
July 1981,
The Journal of antibiotics,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
August 1981,
The Journal of antibiotics,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
August 1983,
The Journal of antibiotics,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
December 1982,
The Journal of antibiotics,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
November 1980,
The Journal of antibiotics,
A Yoshimoto, and
O Johdo, and
T Ishikura, and
T Takeuchi
August 2003,
Applied microbiology and biotechnology,
